跳至主要内容
临床试验/EUCTR2011-003030-14-IT
EUCTR2011-003030-14-IT进行中(未招募)不适用

erve Growth Factor (NGF) eye drop administration as visual rescue treatment in visual loss-associated optic gliomas. - NGF in the optic gliomas

POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI0 个研究点开始时间: 2012年9月3日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • children with established diagnosis of Optic Gliomas (OG)
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 22
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 2
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • children with OG associated with NF1 in RC treatment or have to finish treatment program till 12 mounths

研究者

发起方
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI

相似试验

erve Growth Factor (NGF) eye drop administration as... | 临床试验